Human umbilical cord blood stem cells, myocardial infarction and stroke

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 9, Issue 4, 2009, Pages 342-345

  Copeland, Nathan ^a   Harris, David ^b   Gaballa, Mohamed A ^c,d,e  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c SUN HEALTH RESEARCH INSTITUTE   (United States)

^d Banner GoodSam Medical Center   (United States)

^e NONE   (United States)

Author keywords

Animal models; Cerebral infarction; Myocardial infarction; Stem cells; Umbilical cord blood

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; CD34 SELECTION; CEREBROVASCULAR ACCIDENT; CORD BLOOD STEM CELL TRANSPLANTATION; GENE EXPRESSION; HEART EJECTION FRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE PERFUSION; HUMAN; INTERMETHOD COMPARISON; NEUROPROTECTION; NONHUMAN; REVIEW; TISSUE REGENERATION; UMBILICAL CORD BLOOD;

EID: 70249138763     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.9-4-342     Document Type: Review

References (37)

1. Valina C, Pinkernell K, Song YH et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 2007;28:2667-77.
2. Zhang DZ, Gai LY, Liu HW et al. Transplantation of autologous adipose-derived stem cells ameliorates cardiac function in rabbits with myocardial infarction. Chin Med J (Engl) 2007;120:300-7.
3. Kang SK, Lee DH, Bae YC et al. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 2003;183:355-66.
4. Hoogduijn MJ, Crop MJ, Peeters AM et al. Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev 2007;16:597-604.
5. Payne TR, Oshima H, Okada M et al. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol 2007;50:1677-84.
6. Herreros J, Prósper F, Perez A et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003;24:2012-20.
7. Goldberg JL, Laughlin MJ, Pompili VJ. Umbilical cord blood stem cells: implications for cardiovascular regenerative medicine. J Mol Cell Cardiol 2007;42:912-20.
8. Wu KH, Yang SG, Zhou B et al. Human umbilical cord derived stem cells for the injured heart. Med Hypotheses 2007;68:94-7.
9. Zhang L, Yang R, Han ZC. Transplantation of umbilical cord blood-derived endothelial progenitor cells: A promising method of therapeutic revascularisation. Eur J Haematol 2006;76:1-8.
10. Leor J, Guetta E, Chouraqui P, Guetta V, Nagler A. Human umbilical cord blood cells: A new alternative for myocardial repair? Cytotherapy 2005;7:251-7.
11. Scheinowitz M. Therapeutic myocardial angiogenesis: Past, present and future. Mol Cell Biochem 2004;264:75-83.
12. Chang CK, Chang CP, Chiu WT, Lin MT. Prevention and repair of circulatory shock and cerebral ischemia/injury by various agents in experimental heatstroke. Curr Med Chem 2006;13:3145-54.
13. Sanchez-Ramos J. Stem cells from umbilical cord blood. Semin Reprod Med 2006;24:358-69.
14. Liu HY, Zhang QJ, Li HJ, Han ZC. Effect of intracranial transplantation of CD34+ cells derived from human umbilical cord blood in rats with cerebral ischemia. Chin Med J (Engl) 2006;119:1744-8.
15. Garbuzova-Davis S, Willing AE, Saporta S et al. Novel cell therapy approaches for brain repair. Prog Brain Res 2006;157:207-22.
16. Sanberg PR, Willing AE, Garbuzova-Davis S et al. Umbilical cord blood-derived stem cells and brain repair. Ann N Y Acad Sci 2005;1049:67-83.
17. Wu X, Kochanek PM. Should we add stem cells to the code cart in resuscitation of heatstroke? Crit Care Med 2005;33:1458-9.
18. Wu KH, Zhou B, Yu CT et al. Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann Thorac Surg 2007;83:1491-8.
19. Kim BO, Tian H, Prasongsukarn K et al. Cell transplantation improves ventricular function after a myocardial infarction: A preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 2005;112:I96-104.
20. Henning RJ, Burgos JD, Ondrovic L et al. Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size. Cell Transplant 2006;15:647-58.
21. Hu CH, Wu GF, Wang XQ et al. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction. Chin Med J (Engl) 2006;119:1499-506.
22. Ma N, Ladilov Y, Moebius JM et al. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells. Cardiovasc Res 2006;71:158-69.
23. Leor J, Guetta E, Feinberg MS et al. Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium. Stem Cells 2006;24:772-80.
24. Chen HK, Hung HF, Shyu KG et al. Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction. Eur J Clin Invest 2005;35:677-86.
25. Ott I, Keller U, Knoedler M et al. Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J 2005;19:992-4.
26. Moelker AD, Baks T, Wever KM et al. Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine. J Mol Cell Cardiol 2007;42:735-45.
27. Xiao J, Nan Z, Motooka Y, Low WC. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev 2005;14:722-33.
28. Vendrame M, Gemma C, Pennypacker KR et al. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol 2006;199:191-200.
29. Meier C, Middelanis J, Wasielewski B et al. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res 2006;59:244-9.
30. Chen SH, Chang FM, Tsai YC et al. Infusion of human umbilical cord blood cells protect against cerebral ischemia and damage during heat-stroke in the rat. Exp Neurol 2006;199:67-76.
31. Vendrame M, Gemma C, de Mesquita D et al. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 2005;14:595-604.
32. Nan Z, Grande A, Sanberg CD, Sanberg PR, Low WC. Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury. Ann N Y Acad Sci 2005;1049:84-96.
33. Nystedt J, Mäkinen S, Laine J, Jolkkonen J. Human cord blood CD34+ cells and behavioral recovery following focal cerebral ischemia in rats. Acta Neurobiol Exp (Wars) 2006;66:293-300.
34. Newcomb JD, Ajmo CT Jr, Sanberg CD et al. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant 2006;15:213-23.
35. Mäkinen S, Kekarainen T, Nystedt J et al. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res 2006;1123:207-15.
36. Newman MB, Willing AE, Manresa JJ, Davis-Sanberg C, Sanberg PR. Stroke-induced migration of human umbilical cord blood cells: Time course and cytokines. Stem Cells Dev 2005;14:576-86.
37. Sunkomat JNE, Harris DT, Hoang Thai, Goldman S, Gaballa MA. Intracoronary delivery of cord blood-derived MNCs & CD34+ cells in an ischemia-reperfusion model. Stem Cells 2009 (in press).